Extending Progression-Free Survival in Ovarian Cancer With Pazopanib
September 25th 2013Andreas du Bois, MD, a professor of gynecologic oncology at Kliniken Essen Mitte in Essen, Germany, discusses a phase III trial exploring the effectiveness of treatment with maintenance pazopanib for patients with advanced ovarian cancer.
Watch
Potential Therapeutic Targets and Molecular Drivers of Inflammatory Breast Cancer
September 24th 2013Komal L. Jhaveri, MD, Assistant Professor, Department of Medicine, NYU Langone Medical Center, discusses the background and results of a study looking at crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).
Watch